Intrinsiqs

Is Merck & Co., Inc. overvalued?

Merck & Co., Inc. (MRK) looks fairly valued — trading about 4% above its fair value.

Fairly valued
Current price $147.76 Fair value $141.50
Price
$147.76
Fair value
$141.50
Current P/E
20.3
Normal P/E
19.4
Market cap
$364.27B
Dividend yield
2.3%
Return on equity
5.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MRK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedNVS Novartis AG